Joseph Group Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.1M Buy
14,086
+694
+5% +$238K 1.07% 35
2026
Q1
$4.71M Buy
13,392
+462
+4% +$165K 1.18% 29
2025
Q4
$4.23M Sell
12,930
-1,537
-11% -$488K 1.11% 33
2025
Q3
$4.08M Buy
14,467
+2,098
+17% +$608K 1.15% 29
2025
Q2
$3.45M Buy
12,369
+1,323
+12% +$375K 1.16% 35
2025
Q1
$3.44M Buy
11,046
+1,112
+11% +$328K 1.32% 27
2024
Q4
$2.59M Buy
9,934
+1,301
+15% +$386K 1.02% 34
2024
Q3
$2.78M Buy
8,633
+1,169
+16% +$382K 1.06% 27
2024
Q2
$2.33M Buy
7,464
+782
+12% +$230K 1.21% 24
2024
Q1
$1.9M Buy
6,682
+6,532
+4,355% +$1.91M 0.95% 33
2023
Q4
$43.2K Hold
150
0.03% 66
2023
Q3
$40.3K Hold
150
0.03% 67
2023
Q2
$33.3K Hold
150
0.03% 64
2023
Q1
$36.3K Hold
150
0.03% 67
2022
Q4
$39K Hold
150
0.04% 72
2022
Q3
$34K Hold
150
0.04% 58
2022
Q2
$36K Hold
150
0.04% 58
2022
Q1
$36K Hold
150
0.04% 57
2021
Q4
$34K Buy
+150
New +$31.7K 0.03% 59

Other funds holding AMGN

Joseph Group Capital Management's AMGN Position: Q2 2026 in Review

Joseph Group Capital Management increased its Amgen (AMGN) stake by 5.2% in Q2 2026, buying an estimated $238K and bringing the position to 14,086 shares worth $5.1M. The position accounts for 1.07% of the portfolio, ranked #35.

Joseph Group Capital Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Joseph Group Capital Management held 14,086 shares of Amgen worth $5.1M as of Q2 2026.
  • Joseph Group Capital Management bought 694 Amgen shares in Q2 2026, an estimated $238K.
  • Amgen made up 1.07% of Joseph Group Capital Management's portfolio in Q2 2026, its #35 holding.
  • Joseph Group Capital Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.